Literature DB >> 30923954

Rheumatology in Poland.

Maria Maślińska1, Tomasz Dobrzyński2,3, Brygida Kwiatkowska2.   

Abstract

The aim of this article is to present the current state of rheumatology in Poland, including the scientific and clinical activity and essential aspects of Polish rheumatic patients' treatment. PubMed, Scopus and Web of Science databases were searched for main keywords: "rheumat*" and affiliation with Poland. Statistical data were obtained from the Central Statistical Office, the National Health Fund and the Polish Chamber of Physicians and Dentists, while the public information from the Polish Society for Rheumatology, the Ministry of Health and the Ministry of Science and Higher Education. Databases of the World Health Organization, the Organization for Economic Co-operation and Development and the European Statistical Office (Eurostat) were used. Most Polish rheumatologists work in large urban agglomerations in the Mazovian, Malopolskie and Silesian Voivodeships. The rheumatologic infrastructure includes 1713 working rheumatologists (> 30% exceeding the age of 60 years), 2301 hospital beds, 2279 outpatient clinics and 955 private practices. Poland's state funding is relatively limited, this problem being addressed by health officials with special treatment programs for biological drugs. The Eurostat data indicate, that in Poland, like in the majority of EU Member States, there's a tendency of specialist/general practitioner ratio rising. The number of scientific publications by Polish rheumatologists has steadily increased in recent years. Poland's rheumatology has made an enormous progress at all levels of functioning in recent decades. The EULAR recommendations are mostly incorporated into the Polish health system, leaving still room for its further improvement in the fields of financing, therapy and education.

Entities:  

Keywords:  Healthcare system; Perspectives; Poland; Publications; Rheumatological care; Rheumatology

Mesh:

Substances:

Year:  2019        PMID: 30923954     DOI: 10.1007/s00296-019-04287-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  5 in total

1.  Current status of the rheumatologists' workforce in Latin America: a PANLAR collaborative study.

Authors:  Daniel Gerardo Fernández-Ávila; Daniela Patino-Hernandez; Sergio Kowalskii; Alfredo Vargas-Caselles; Ana Maria Sapag; Antonio Cachafeiro-Vilar; Lucia Meléndez-Muñoz; Carlos Santiago-Pastelín; Cesar Graf; Chayanne Rossetto; Daniel Palleiro; Daniela Trincado; Diana Fernández-Ávila; Dina Arrieta; Gil Reyes; Jossiel Then Baez; Manuel F Ugarte-Gil; Mario Cardiel; Nelly Colman; Nilmo Chávez; Paula I Burgos; Ruben Montúfar; Sayonara Sandino; Yurilis Fuentes-Silva; Enrique R Soriano
Journal:  Clin Rheumatol       Date:  2021-01-15       Impact factor: 2.980

Review 2.  Rheumatology in Ukraine.

Authors:  Bohdana Doskaliuk; Olena Zimba; Roman Yatsyshyn; Volodymyr Kovalenko
Journal:  Rheumatol Int       Date:  2020-01-02       Impact factor: 2.631

3.  Levelling the playing field of RMD research across Europe to address patients' needs: the emerging EULAR Research Centre.

Authors:  Katja Reuter; Carina Haupt; Anna Molto; Andrew Cope; Ronald F van Vollenhoven; Dirk Elewaut; Rik Lories; Iain B McInnes
Journal:  RMD Open       Date:  2022-06

4.  Trends in psoriatic arthritis epidemiology in Poland.

Authors:  Małgorzata Tłustochowicz; Waldemar Wierzba; Michał Marczak; Witold Tłustochowicz; Andrzej Śliwczyński; Filip Raciborski; Brygida Kwiatkowska; Melania Brzozowska; Andrzej Jacyna; Bartłomiej Kisiel
Journal:  Rheumatol Int       Date:  2020-10-28       Impact factor: 2.631

5.  Improving the quality of life of patients with rheumatoid arthritis after rehabilitation irrespective of the level of disease activity.

Authors:  Daniel Szewczyk; Teresa Sadura-Sieklucka; Beata Sokołowska; Krystyna Księżopolska-Orłowska
Journal:  Rheumatol Int       Date:  2020-10-01       Impact factor: 2.631

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.